文献速递癫痫

激光消融治疗药物难治性癫痫的脑室旁结节状灰质异位

Laser Ablation of Periventricular Nodular Heterotopia for Medically Refractory Epilepsy.
PubMed 文献 · Ann Neurol · 2024-09-19

本研究回顾性分析单中心39例脑室旁结节状灰质异位(PVNH)患者,采用立体脑电图(SEEG)引导的磁共振引导激光间质热疗(MRgLITT)消融癫痫起源区。单侧PVNH无其他影像异常者癫痫无发作率80%,PVNH伴海马硬化或局灶性皮质发育不良者63%,双侧PVNH者50%。消融比例显著影响手术结局(p < 0.001)。

要点

  • SEEG引导MRgLITT消融PVNH及致痫组织,单侧PVNH无其他异常者无发作率80%。
  • PVNH伴MTS或PMG者无发作率63%,双侧PVNH者50%。
  • SoZ消融百分比显著影响手术结局(p < 0.001)。

核心结论

  • PVNH在癫痫起源中起核心作用,MRgLITT是PVNH相关癫痫的变革性技术进展,癫痫控制结局与局灶性病变性癫痫相当。
  • 在局限性单侧病例且其他影像正常时,可考虑不进行有创记录直接消融PVNH,此方法值得进一步探索。

研究设计与样本

  • 回顾性研究,来自单一大容量癫痫转诊中心的连续病例。
  • 39例患者接受SEEG评估后行SEEG引导的MRgLITT,消融癫痫起源区(SoZ)在PVNH及相关癫痫组织。

主要发现

  • PVNH和PMG被密集采样,平均每例16.5(SD = 2)根SEEG电极/209.4(SD = 36.9)个记录触点。
  • 消融主要针对PVNH,影像异常皮质仅在意涉及SoZ时消融(5例)。
  • 体积分析显示PVNH SoZ消融百分比高:单侧病例96.6%(SD = 5.3%),双侧病例92.9%(SD = 7.2%)。
  • 平均随访31.4个月(SD = 20.9)。
  • 癫痫无发作(ILAE 1级):单侧PVNH无其他影像异常者80%;PVNH伴MTS或PMG者63%;双侧PVNH者50%。

临床怎么用

  • 作者认为,在局限性单侧病例且其他影像正常时,可考虑不进行有创记录直接消融PVNH,此方法值得进一步探索。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Periventricular nodular heterotopia (PVNH) is the most common neuronal heterotopia, frequently resulting in pharmaco-resistant epilepsy. Here, we characterize variables that predict good epilepsy outcomes following surgical intervention using stereo-electroencephalography (SEEG) -informed magnetic resonance-guided laser interstitial thermal therapy (MRgLITT). METHODS: A retrospective review of consecutive cases from a single high-volume epilepsy referral center identified patients who underwent SEEG evaluation for PVNH to characterize the intervention and outcomes. RESULTS: Thirty-nine patients underwent SEEG-guided MRgLITT of the seizure onset zone (SoZ) in PVNH and associated epileptic tissue. PVNH and polymicrogyria (PMG) were densely sampled with a mean of 16.5 (SD = 2)/209.4 (SD = 36.9) SEEG probes/recording contacts per patient. Ablation principally targeted just the PVNH and cortex that was abnormal on imaging was ablated (5 patients) only if implicated in the SoZ. Volumetric analyses revealed a high percentage of PVNH SoZ ablation (96.6%, SD = 5.3%) in unilateral and bilateral (92.9%, SD = 7.2%) cases. Mean follow-up duration was 31.4 months (SD = 20.9). Seizure freedom (ILAE 1) was excellent: unilateral PVNH without other imaging abnormalities, 80%; PVNH with mesial temporal sclerosis (MTS) or PMG, 63%; bilateral PVNH, 50%. SoZ ablation percentage significantly impacted surgical outcomes (p < 0.001). INTERPRETATION: PVNH plays a central role in seizure genesis as revealed by dense recordings and selective targeting by LITT. MRgLITT represents a transformative technological advance in PVNH-associated epilepsy with seizure control outcomes consistent with those seen in focal lesional epilepsies. In localized unilateral cases and otherwise normal imaging, PVNH ablation without invasive recordings may be considered, and this approach deserves to be explored further. ANN NEUROL 2024;96:1174-1184.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. McCormack RM, Chandran AS, Lhatoo SD, et al. Laser Ablation of Periventricular Nodular Heterotopia for Medically Refractory Epilepsy. Ann Neurol. 2024. PMID: 39297387. doi:10.1002/ana.27059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。